cyclin T2 Inhibitors

Cyclin T2, a member of the cyclin family, partners with cyclin-dependent kinases (CDKs), especially CDK9, to form the positive transcription elongation factor b (P-TEFb) complex. This complex plays a crucial role in RNA polymerase II-dependent transcription. There are inhibitors that target the P-TEFb complex or CDK9, which indirectly affect Cyclin T2's function. These molecules primarily target the kinase activity associated with the P-TEFb complex. By inhibiting CDK9, they can potentially modulate the function of Cyclin T2, given its interaction with CDK9.

Cyclin T2 inhibitors belong to a class of molecules that modulate the function of cyclin T2, a member of the cyclin protein family. Cyclin T2, along with other cyclins, plays a vital role in cell cycle regulation by forming complexes with cyclin-dependent kinases (CDKs). Specifically, cyclin T2 primarily associates with CDK9 to form the positive transcription elongation factor b (P-TEFb) complex. This P-TEFb complex is instrumental in controlling RNA polymerase II-dependent transcription, thereby influencing gene expression across the cell. The formation of the P-TEFb complex is crucial for transitioning from the transcription initiation phase to the transcription elongation phase.